Autoplaque vs syngo.CT CaScoring
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a comprehensive, AI-powered quantitative analysis of both calcified and non-calcified coronary plaques, along with precise measurement of luminal stenoses from CT angiography images. This tool is ideal for clinicians requiring detailed insights into the full spectrum of atherosclerotic plaque burden and vessel narrowing to inform heart attack risk prediction and treatment strategies.
View Autoplaque →Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if your main objective is rapid and accurate quantification of calcified coronary lesions for cardiovascular risk assessment using standard calcium scoring methods. This tool is best suited for scenarios where calculating the Agatston Score, volume, and calcium mass is sufficient, providing a quick and standardized way to assess plaque burden and compare it against reference populations.
View syngo.CT CaScoring →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | syngo.CT CaScoring |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AutoplaqueAutoplaque's workstation-based deployment on common operating systems like Windows or Mac offers broader accessibility and flexibility for users across different IT environments. While syngo.CT CaScoring is well-integrated within the Siemens ecosystem, its vendor-specific platform might limit its usability for institutions not primarily using Siemens CT systems.
Clinical Value
AutoplaqueAutoplaque offers a more comprehensive clinical assessment by providing quantitative analysis of all coronary plaques (including non-calcified) and luminal stenoses, which is crucial for detailed heart attack risk prediction and treatment guidance. While syngo.CT CaScoring provides valuable calcium scoring, Autoplaque's broader plaque characterization offers a deeper insight into atherosclerotic disease.
Pricing & Value
syngo.CT CaScoringsyngo.CT CaScoring provides some historical pricing information and indicates a one-time license purchase model, offering a degree of transparency regarding its cost structure. In contrast, Autoplaque's pricing is not disclosed, making it impossible to assess its value or compare costs effectively.
Enterprise Readiness
syngo.CT CaScoringAs a product from Siemens Medical Solutions, syngo.CT CaScoring benefits from a robust enterprise infrastructure, including likely HIPAA compliance and BAA offerings, and integration with the scalable syngo.via client/server platform. Autoplaque, originating from an academic medical center, has not specified these critical enterprise compliance and deployment details, suggesting potentially more effort for large-scale integration.
Innovation
AutoplaqueAutoplaque demonstrates greater innovation by providing comprehensive AI-powered quantitative analysis of all coronary plaque types (calcified and non-calcified) and luminal stenoses, offering a more advanced and detailed assessment of atherosclerotic disease. While calcium scoring is a valuable and established method, Autoplaque's broader characterization pushes the boundaries of current risk assessment.
Support & Docs
syngo.CT CaScoringSiemens, as a major healthcare technology vendor, provides a comprehensive and well-documented support ecosystem for syngo.CT CaScoring, including extensive documentation, training programs, remote services, and a user community. Autoplaque, while having a user manual, lacks publicly available information detailing a comparable level of commercial support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | syngo.CT CaScoring |
|---|---|---|
| Name | Autoplaque | syngo.CT CaScoring |
| Company | Cedars-Sinai Medical Center: AIM | Siemens Medical Solutions USA |
| Description | FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation. |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | Quick quantification of calcified coronary lesions; Accurate visualization of calcified coronary lesions; Calculation of Agatston Score, volume, and calcium mass; Assessment of plaque burden in total and per coronary artery (RCA, LM, LAD, CX); Automatic highlighting of coronary calcifications; User-modifiable threshold for score calculation (default 130 HU); Comparison of patient score to healthy reference groups (e.g., MESA study); Calculation of 'Coronary Age' |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and syngo.CT CaScoring.